Efficacy and safety of obinutuzumab combined with fludarabine and cyclophosphamide (FCG) or bendamustine (BG) in relapsed or refractory CLL patients followed by maintenance therapy with obinutuzumab for responding patients
Kutsch, Nadine, Holmes, Emily Eva, Robrecht, Sandra, Schüler, Gudrun, Vehling-Kaiser, Ursula, Decker, Thomas, Müller-Hagen, Sigrun, Heinisch, Karin, Böttcher, Sebastian, Ritgen, Matthias, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Fink, Anna Maria, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael, Wendtner, Clemens-Martin
Published in Leukemia & lymphoma (28.01.2023)
Published in Leukemia & lymphoma (28.01.2023)
Get full text
Journal Article
Initiative on #4openScienceStandsForUkraine scientists and students
Brücher, Björn LDM, Brembs, Björn, Bartsch, Detlef, Przygodzki, Ronald, Gosselin, Romain-Daniel, Rupnik, Marijan Slak, Calu, Valentin, Birkenmaier, Christof, Hayden, Oliver, Schmidt, Annette, Elias, Nelson, Stein, Hubert J, Restrepo, Cesar, Pliquett, Rainer U, Petersen, Björn, Spychalla, Arkadiusz, Nguyen, David H, Santos, Lúcio Lara, Szold, Amir, Tez, Mesut, Roviello, Franco, Macri, Paolo, Loroch, Vanya, Scherer, Michael A, Pasche, Boris, Polom, Karol, Wesarg, Stefan, Matevossian, Edouard, Zilberstein, Bruno, Kryvoruchko, Igor A, Correia da Costa, José M, Nigri, Giuseppe, Weissig, Volkmar, Ralon, Sergio, Kermansaravi, Mohammad, Oleas, Raúl, Seno, Masaharu, Baum, Michael, Voskuil, Jan, Mintz, Yoav, Rödiger, Stefan, Schueler, Gudrun, Kühn, Hartmut, Delrio, Paolo, Wallner, Grzegorz, Rivkind, Avraham, Nieminen, Pentti, Armstrong, David G, Schlegel, Martin P, Daumer, Martin, Ööpik, Vahur, Araujo, Raimund JC, Lapeña, Jose Florencio F, Perkins, Ray, Anogianakis, Georgios, Salber, Jochen, Tenne, Reshef, Jamall, Ijaz S
Published in 4Open (2022)
Published in 4Open (2022)
Get full text
Journal Article